Cancer Treatment
Findings from Italy and the United States describe new data in cancer treatment research
Published in Gene Therapy Weekly, October 12th, 2006
Study 1: According to a study from Italy, treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter (NIS) complementary deoxyribonucleic acid.
"One of the major limits of gene therapy with NIS, which enables cells to be subjected to radioiodine therapy, is that NIS-transfected cells rapidly release the intracellular iodine," wrote R. Elisei and colleagues, University of Pisa.
"We transfected human anaplastic (FRO) and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-10-12)
More Articles from Gene Therapy Weekly
- Antisense Technology
Neurodegenerative disease therapy can utilize antisense oligonucleotides - Colitis
Colitis therapeutic target identified - Gene Silencing
Myostatin silenced in embryonic myoblast differentiation - Neuroscience
Heterotopia formation occurs in rat neocortex after RNA interference knockdown - Stem Cell Research
Embryonic stem cell reversible gene expression induced by a RNA vector - Adverse Drug Reaction
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate documented - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
